Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs

Chronic lymphocytic leukemia (CLL) caregivers play a central role in disease management—a role that has been heightened during the COVID-19 pandemic given the healthcare system’s reliance on frontline family caregivers and CLL patients’ increased risk of infection and mortality. Using a mixed-method...

Full description

Bibliographic Details
Main Authors: Diliara Bagautdinova, Kelsey C. Bacharz, Carma L. Bylund, Maria Sae-Hau, Elisa S. Weiss, Michelle Rajotte, Greg Lincoln, Taylor S. Vasquez, Naomi D. Parker, Kevin B. Wright, Carla L. Fisher
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/4/1648
Description
Summary:Chronic lymphocytic leukemia (CLL) caregivers play a central role in disease management—a role that has been heightened during the COVID-19 pandemic given the healthcare system’s reliance on frontline family caregivers and CLL patients’ increased risk of infection and mortality. Using a mixed-method design, we investigated the impact of the pandemic on CLL caregivers (Aim 1) and their perceived resource needs (Aim 2): 575 CLL caregivers responded to an online survey; 12 spousal CLL caregivers were interviewed. Two open-ended survey items were thematically analyzed and compared with interview findings. Aim 1 results showed that two years into the pandemic, CLL caregivers continue to struggle with <i>coping with distress, living in isolation, and losing in-person care opportunities</i>. Caregivers described experiencing <i>increasing caregiving burden, realizing the vaccine may not work or didn’t work for their loved one with CLL, feeling cautiously hopeful about EVUSHELD</i>, and <i>dealing with unsupportive/skeptical individuals</i>. Aim 2 results indicate that CLL caregivers needed <i>reliable, ongoing information about COVID-19 risk, information about and access to vaccination, safety/precautionary measures,</i> and <i>monoclonal infusions</i>. Findings illustrate ongoing challenges facing CLL caregivers and provide an agenda to better support the caregivers of this vulnerable population during the COVID-19 pandemic.
ISSN:2077-0383